SOURCE: Tergus Pharma

Tergus Pharma

April 20, 2016 10:11 ET

Tergus Creates Several Key Positions and Attracts Top Talent

James Varner and Lance Rogers Will Lead Analytical R&D and Project Management

DURHAM, NC--(Marketwired - Apr 20, 2016) -  Tergus Pharma, (www.terguspharma.com), the industry leader in topical development, formulation, analysis, testing and clinical supply manufacturing has hired James Varner as a Senior Manager of Analytical R&D and Lance Rogers as Project Management Leader. Varner will lead late-stage development and optimization, method validation, Quality Control release and stability testing and scale up protocols. Rogers will grow and set the direction for the project management department. The hiring of Mr. Varner and Mr. Rogers, as well as a number of other key hires, will further the company's growth and expansion.

Tergus is the industry leader in topical pharmaceutical development, skin biology & IVRT testing and Phase I - III cGMP clinical supply manufacturing. Mr. Varner has deep expertise in all phases of pharmaceutical development in a number of dosage forms. Mr. Rogers is an expert in pharmaceutical project management.

"We are pleased that James Varner and Lance Rogers have joined the company," said Vijendra Nalamothu, PhD, CEO and co-founder of Tergus. "Both are consummate professionals who will help us to continue to grow while providing stellar service to our clients."

Mr. Varner earned his bachelor's degree in Chemistry from the University of North Carolina at Chapel Hill. He has a strong analytical background with a broad range of dosage forms and compound types. He was the lead developer for numerous products specializing in molecules that did not possess a chromophore, through analysis on HPLC-ELSD and HPLC-CAD. He paved the way for a new analysis direction of lipid and oil matrix component assay in drug products through novel HPLC method design. In addition, he was able to take multiple projects from inception, working with formulation development to determine and optimize new drug products, through cGMP stability programs supporting clinical batches.

Mr. Rogers has more than 18 years of experience in project management and in ensuring that projects are completed on time and within budget. He has an exceptional track record leading global matrix teams to develop and deliver medicines of value. He has deep expertise in developing and executing organization strategy to lead the development of pharmaceuticals, managing resources and delivering positive results. He has extensive knowledge in collaborating with internal and external teams and leadership involved in all phases of development, formulation, analysis, testing and manufacturing.

Tergus has enjoyed strong growth for the past few years and has attracted top talent in topical formulation, development, testing, analysis and manufacturing. It continues to grow its footprint, recently expanding to a more than 28,000 square-foot facility that includes top-of-the-line R&D labs, cGMP manufacturing suite and the largest capability in the industry for IVRT and skin permeation studies. Tergus pioneered QbD for topical pharmaceuticals and continues to innovate and develop strategies that result in greater success for its clients. 

Tergus offers complete topical pharmaceutical consulting services, development, formulation, analytical R&D, In Vitro Release Testing (IVRT), skin biology and cGMP clinical supplies manufacturing. The company has capability to produce clinical supplies up to 150kg using their state of the art manufacturing equipment. The company's motto is "Think Topical, Think Tergus."

About Tergus
Tergus (www.terguspharma.com) is the market leader in full-service topical pharmaceutical research, development, testing, analysis and manufacturing. The company has more than 20 years in business located in a state-of-the-art laboratory facility in Durham, North Carolina. The company has a long and stellar reputation for delivering quality and results for clients from formulation through manufacturing. Tergus pioneered Quality by Design (QbD) protocols for semi-solid delivery forms and has the largest bank of In Vitro Release Testing (IVRT) Franz Diffusion cells. The company's motto is "Think Topical. Think Tergus."

Contact Information

  • Michele Borek
    Tergus Pharma
    (919) 908-0564